JPS61213671A - ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法 - Google Patents
ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法Info
- Publication number
- JPS61213671A JPS61213671A JP5420885A JP5420885A JPS61213671A JP S61213671 A JPS61213671 A JP S61213671A JP 5420885 A JP5420885 A JP 5420885A JP 5420885 A JP5420885 A JP 5420885A JP S61213671 A JPS61213671 A JP S61213671A
- Authority
- JP
- Japan
- Prior art keywords
- plasmin
- antibody
- human
- alpha2
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002806 plasmin inhibitor Substances 0.000 title claims abstract description 22
- 229940122791 Plasmin inhibitor Drugs 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims description 27
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940012957 plasmin Drugs 0.000 claims abstract description 20
- 101000783712 Homo sapiens Alpha-2-antiplasmin Proteins 0.000 claims abstract 3
- 108010088842 Fibrinolysin Proteins 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- 238000003018 immunoassay Methods 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims 1
- 238000002372 labelling Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 4
- 238000005259 measurement Methods 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000020764 fibrinolysis Effects 0.000 abstract description 2
- 239000004033 plastic Substances 0.000 abstract description 2
- 229920003023 plastic Polymers 0.000 abstract description 2
- 230000001268 conjugating effect Effects 0.000 abstract 3
- 210000002381 plasma Anatomy 0.000 abstract 2
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 abstract 1
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 17
- 239000003112 inhibitor Substances 0.000 description 11
- 210000004408 hybridoma Anatomy 0.000 description 9
- 206010035226 Plasma cell myeloma Diseases 0.000 description 6
- 201000000050 myeloid neoplasm Diseases 0.000 description 6
- 230000004927 fusion Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 210000005265 lung cell Anatomy 0.000 description 4
- 101000605403 Homo sapiens Plasminogen Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- ZBRZSJUFJUMKIM-UHFFFAOYSA-N 3-(1-phenylpropan-2-ylamino)propanenitrile;hydrochloride Chemical compound Cl.N#CCCNC(C)CC1=CC=CC=C1 ZBRZSJUFJUMKIM-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 101100256223 Caenorhabditis elegans cho-1 gene Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 241001026509 Kata Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5420885A JPS61213671A (ja) | 1985-03-20 | 1985-03-20 | ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法 |
DE19853586577 DE3586577T2 (de) | 1984-07-26 | 1985-07-23 | Immunologische bestimmung von menschlichem plasmin/alpha-2-plasmin-hemmstoff. |
EP19850109227 EP0169549B1 (en) | 1984-07-26 | 1985-07-23 | Immunological determination of human plasmin/alpha2-plasmin inhibitor |
DK339985A DK339985A (da) | 1984-07-26 | 1985-07-25 | Immunologisk bestemmelse af humanplasmin/alfa2-plasmininhibitor samt reagenssystem til brug herved |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5420885A JPS61213671A (ja) | 1985-03-20 | 1985-03-20 | ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61213671A true JPS61213671A (ja) | 1986-09-22 |
JPH0535827B2 JPH0535827B2 (enrdf_load_stackoverflow) | 1993-05-27 |
Family
ID=12964132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5420885A Granted JPS61213671A (ja) | 1984-07-26 | 1985-03-20 | ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61213671A (enrdf_load_stackoverflow) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63247661A (ja) * | 1987-04-02 | 1988-10-14 | Nisshin Flour Milling Co Ltd | アミラ−ゼインヒビタ−の定量方法 |
WO1992011384A1 (en) * | 1990-12-20 | 1992-07-09 | Iatron Laboratories, Inc. | ANTIBODY AGAINST HUMAN PLASMIN-α2-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY |
JPH06300757A (ja) * | 1993-04-12 | 1994-10-28 | Fuji Yakuhin Kogyo Kk | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5356308A (en) * | 1976-03-18 | 1978-05-22 | Leuven Res & Dev Vzw | Antiplasmin and its antiserum |
JPS5665896A (en) * | 1979-10-31 | 1981-06-03 | Mochida Pharmaceut Co Ltd | Preparation of alpha2-plasmin inhibitor |
JPS5716355A (en) * | 1980-04-25 | 1982-01-27 | Hoffmann La Roche | Immunological method |
JPS57136165A (en) * | 1981-02-18 | 1982-08-23 | Mochida Pharmaceut Co Ltd | Immunological measuring reagent |
JPS5954966A (ja) * | 1982-09-22 | 1984-03-29 | Mochida Pharmaceut Co Ltd | 免疫学的測定試薬 |
-
1985
- 1985-03-20 JP JP5420885A patent/JPS61213671A/ja active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5356308A (en) * | 1976-03-18 | 1978-05-22 | Leuven Res & Dev Vzw | Antiplasmin and its antiserum |
JPS5665896A (en) * | 1979-10-31 | 1981-06-03 | Mochida Pharmaceut Co Ltd | Preparation of alpha2-plasmin inhibitor |
JPS5716355A (en) * | 1980-04-25 | 1982-01-27 | Hoffmann La Roche | Immunological method |
JPS57136165A (en) * | 1981-02-18 | 1982-08-23 | Mochida Pharmaceut Co Ltd | Immunological measuring reagent |
JPS5954966A (ja) * | 1982-09-22 | 1984-03-29 | Mochida Pharmaceut Co Ltd | 免疫学的測定試薬 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63247661A (ja) * | 1987-04-02 | 1988-10-14 | Nisshin Flour Milling Co Ltd | アミラ−ゼインヒビタ−の定量方法 |
WO1992011384A1 (en) * | 1990-12-20 | 1992-07-09 | Iatron Laboratories, Inc. | ANTIBODY AGAINST HUMAN PLASMIN-α2-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY |
JPH06300757A (ja) * | 1993-04-12 | 1994-10-28 | Fuji Yakuhin Kogyo Kk | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
Also Published As
Publication number | Publication date |
---|---|
JPH0535827B2 (enrdf_load_stackoverflow) | 1993-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5855886A (en) | Antibodies, and methods for their use | |
JP5807300B2 (ja) | 試料中のc反応性蛋白質の測定方法及び測定試薬 | |
JP3517754B2 (ja) | 抗ヒト可溶性フィブリン抗体,ハイブリドーマ及び免疫学的測定法 | |
KR20170132310A (ko) | 트롬빈 안티트롬빈 복합체의 측정 시약 및 측정 방법 | |
JP2012082210A (ja) | Adamts13活性検定用抗体及び活性検定方法 | |
JPS61213671A (ja) | ヒトプラスミン−α↓2−プラスミンインヒビタ−複合体の測定法 | |
JPH04507285A (ja) | 抗イディオトープ免疫検定法 | |
EP0339302A1 (en) | Reagent system for immunologically assaying complex of human plasminogen activator inhibitor and human tissue plasminogen activator, and assay kit therefor | |
JP3888695B2 (ja) | ヒトlect2に対する抗体、それを産生する細胞、その測定法及び測定用キット | |
JP2518602B2 (ja) | ヒトプロテインsに対するモノクロ―ナル抗体を用いた免疫学的測定試薬及びキット | |
JPH07508103A (ja) | トロンビン−アンチトロンビン3複合体のためのイムノアッセイ及び試験キット | |
US7541159B2 (en) | Molecular-specific urokinase antibodies | |
JP2507317B2 (ja) | プラスミン―α2プラスミンインヒビタ―複合体の測定方法 | |
EP0169549A2 (en) | Immunological determination of human plasmin/alpha2-plasmin inhibitor | |
JPS61213670A (ja) | ヒトα↓2−プラスミンインヒビタ−の測定方法 | |
JPS61286753A (ja) | モノクロ−ナル抗体を用いた免疫学的測定方法およびそのためのキツト | |
JPH07117534B2 (ja) | ヒトプロテインsに対するモノクローナル抗体を用いた免疫学的測定試薬及びキット | |
JPS6265693A (ja) | 活性型ヒト血液凝固第▲xi▼因子の免疫学的定量法 | |
JPS6134465A (ja) | ヒトα↓2−プラスミンインヒビタ−に対するモノクロ−ナル抗体を用いた免疫学的測定試薬及びキツト | |
JP2003004748A (ja) | 膵臓癌診断用試薬 | |
JPS60231168A (ja) | ヒトα2―プラスミンインヒビターに対するモノクローナル抗体を用いた免疫学的測定試薬及びキット | |
JPH07117535B2 (ja) | ヒトプロテインsに免疫学的測定方法、それに用いる測定試薬及びキット | |
JP2002112768A (ja) | アンジオスタチン特異的モノクローナル抗体、及びこのモノクローナル抗体を用いたアンジオスタチンの検出方法等 | |
HU201844B (en) | Immun adsorptive-amidolytic method for detecting plasminogen activator precursor (pro-uppa) and plasminogen activator (upa) of the human urine | |
JPH04211363A (ja) | 二重特異性を有するハイブリッドモノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |